Skip to content
Viagra LabsViagra Labs
Menu
Silagra 100 mg
Silagra 100 Packaging Blisters
Silagra 100 mg

Silagra (sildenafil)

Silagra is a sildenafil brand associated with Cipla in the source record.

Active ingredient
sildenafil
Formulation
Oral tablet
Company in catalogue
Cipla Ltd

Silagra is a sildenafil brand associated with Cipla in the source record. The listed tablet strengths are 50 and 100 mg. Suhagra is another Cipla-associated sildenafil name in this catalogue, but has a separate profile and strength list.

What distinguishes this product

Cipla’s identity is a useful company signal when assessing a product source. It does not by itself identify the manufacturing site or establish registration of a particular Silagra pack in Australia, Singapore, the UK or another market.

Product record

Record type
Indian branded generic
Treatment area in this directory
Erectile dysfunction (ED)
Active ingredient
sildenafil
Formulation in the cited record
Oral tablet
Source-listed strengths
50 mg, 100 mg
Company in the cited record
Cipla Ltd (Company attributed by the source catalogue)
Manufacturing information
A specific manufacturing site is not established by the cited catalogue record. Consult the country-specific label and pack.
Market evidence
Global reference; exact market authorization not established by this catalogue import
Storage reported by source
Store below 30°C Check the supplied leaflet for the exact presentation.
Catalogue reviewed

Catalogue attributes describe the named product as reported by the source. Listed strengths are identification details, not dosing instructions. Ingredient evidence and company identity are useful signals; local product authorization is a separate question.

Ingredient references

These references cover the active ingredients. They do not verify every named brand, pack or formulation listed on this page.

How the ingredients fit treatment

Sildenafil supports the erection response to sexual stimulation by inhibiting PDE5. It is used before sexual activity in ED treatment; it is not a libido stimulant. Food can affect the response, so use the instructions for the prescribed presentation.

Ingredient guidance and safe use

Read the ingredient guidance alongside the leaflet for the actual product. A different brand, strength or dosage form may need different instructions.

Do not combine a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing. Tell the treating team which medicine you took and when.

Commonly reported effects of oral PDE5 medicines include headache, flushing, indigestion and nasal congestion; the pattern varies by ingredient and product. The cited ingredient information covers adverse effects and restrictions in more detail.

Interactions and urgent symptoms · Understanding formulations · Finding a local medicine record

Related product records